3pds
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Irreversible Agonist-Beta2 Adrenoceptor Complex== | ==Irreversible Agonist-Beta2 Adrenoceptor Complex== | ||
<StructureSection load='3pds' size='340' side='right' caption='[[3pds]], [[Resolution|resolution]] 3.50Å' scene=''> | <StructureSection load='3pds' size='340' side='right' caption='[[3pds]], [[Resolution|resolution]] 3.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3pds]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3pds]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PDS OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3PDS FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ERC:8-HYDROXY-5-[(1R)-1-HYDROXY-2-({2-[3-METHOXY-4-(3-SULFANYLPROPOXY)PHENYL]ETHYL}AMINO)ETHYL]QUINOLIN-2(1H)-ONE'>ERC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=ERC:8-HYDROXY-5-[(1R)-1-HYDROXY-2-({2-[3-METHOXY-4-(3-SULFANYLPROPOXY)PHENYL]ETHYL}AMINO)ETHYL]QUINOLIN-2(1H)-ONE'>ERC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2rh1|2rh1]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2rh1|2rh1]]</td></tr> | ||
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3pds FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3pds OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3pds RCSB], [http://www.ebi.ac.uk/pdbsum/3pds PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3pds FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3pds OCA], [http://pdbe.org/3pds PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3pds RCSB], [http://www.ebi.ac.uk/pdbsum/3pds PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3pds ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
Line 19: | Line 20: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 3pds" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
*[[Adrenergic receptor|Adrenergic receptor]] | *[[Adrenergic receptor|Adrenergic receptor]] | ||
+ | *[[Beta-2 adrenergic receptor|Beta-2 adrenergic receptor]] | ||
*[[Lysozyme 3D structures|Lysozyme 3D structures]] | *[[Lysozyme 3D structures|Lysozyme 3D structures]] | ||
== References == | == References == | ||
Line 27: | Line 30: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Human]] |
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Aragao, D]] | [[Category: Aragao, D]] |
Revision as of 15:45, 4 August 2016
Irreversible Agonist-Beta2 Adrenoceptor Complex
|
Categories: Human | Lysozyme | Aragao, D | Arlow, D H | Caffrey, M | Chae, P S | Choi, H J | DeVree, B T | Dror, R O | Gellman, S H | Gmeiner, P | Holl, R | Kobilka, B K | Lyons, J A | Rasmussen, S G.F | Rosenbaum, D M | Shaw, D E | Sunahara, R K | Weis, W I | Zhang, C | Beta adrenergic agonist | Fusion protein | Gpcr | Membrane protein-hydrolase complex | Signaling